I conducted a small data study to calculate the number of semaglutide clinics by city and state and analyze their correlation with obesity rates.<p>I started the directory itself because I was helping a med spa clinic with their marketing and couldn’t find any existing directories specifically for semaglutide clinics. So, I decided to build one myself.<p>Given I already had this data, I thought it would be interesting and helpful to share it publicly.<p>Key Findings:<p>-There is a moderate negative correlation between a state's obesity rate and the number of its per-capita semaglutide clinics. States with a higher obesity rate have a lower number of semaglutide clinics.<p>-There are approximately 3,490 semaglutide clinics in the U.S.<p>-Utah, New Hampshire, and Florida have the most semaglutide clinics per capita.<p>-4% of all U.S. cities have at least one semaglutide clinic.<p>We are also nearing the completion of a pricing study. The pricing study will compare the cost of semaglutide injections across thousands of clinics in the U.S., breaking it down by the average cost per city and state. We’ll also be using this pricing data to add a cost filter to the directory's frontend.<p>Future Research Plans:<p>-Top rated semaglutide providers by state<p>-Average price of tirzepatide (nationally and by state)<p>-Top rated semaglutide providers that accept insurance<p>Would love your feedback on how to improve our data study (and the site overall) before we circulate it more widely. Thank you!
This is awesome, thanks for doing it -- the data looks high quality, and the layout is fantastic!<p>I think it might be a bit early to accurately attribute a negative correlation between clinics and obesity rates at a state level but.<p>It also might have been good to spell out <i>exactly</i> what the research means by by "Semaglutide clinic".
This is interesting! Great job. Interesting that high obesity states have a lower number of clinics, but of course states with a lower GDP per capita have a higher obesity rate. Still, interesting to see that confirmed with real data.
Have you checked out where there seems to be untapped market need/opportunity? i.e. disproportionately high-obesity states with disproportionately-low density of clinics?